HomepageSMZ1 • FRA
add
Sino Biopharmaceutical Ltd
Vorige slotkoers
€ 0,34
Jaar-range
€ 0,29 - € 0,49
Beurswaarde
53,96Â mld. HKD
Gem. volume
1,76K
Koers/winst
-
Dividendrendement
-
Primaire beurs
HKG
Marktnieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
| (CNY) | dec 2023info | Wijziging j-o-j |
|---|---|---|
Opbrengst | — | — |
Bedrijfskosten | — | — |
Netto inkomsten | — | — |
Netto winstmarge | — | — |
Winst per aandeel | — | — |
EBITDA | — | — |
Effectief belastingtarief | — | — |
Balans
Totale activa
Totale passiva
| (CNY) | dec 2023info | Wijziging j-o-j |
|---|---|---|
Contanten en kortetermijnbeleggingen | 14,12Â mld. | -16,57% |
Totale activa | 63,60Â mld. | -0,72% |
Totale passiva | 25,43Â mld. | -2,63% |
Totaal aandelenvermogen | 38,17 mld. | — |
Uitstaande aandelen | 18,35 mld. | — |
Koers-boekwaardeverhouding | 0,20 | — |
Rendement op activa | — | — |
Rendement op kapitaal | — | — |
Kasstroom
Nettomutatie in liquide middelen
| (CNY) | dec 2023info | Wijziging j-o-j |
|---|---|---|
Netto inkomsten | — | — |
Operationele kasstroom | — | — |
Kasstroom uit beleggingen | — | — |
Kasstroom uit financiering | — | — |
Nettomutatie in liquide middelen | — | — |
Vrije kasstroom | — | — |
Over
Sino Biopharmaceutical Limited, shortly Sino Biopharm, is a civilian-run enterprise principally engaged in the medicine products business in Mainland China.
Being a member of Charoen Pokphand Group and headquartered in Hong Kong and Beijing, Sino Biopharm is engaged in researching, developing, producing, and selling biopharmaceutical products for the medical treatment of ophthalmia, as well as modernized Chinese medicine and chemical medicine for the treatment of hepatitis through its subsidiaries.
Sino Biopharm is also involved in other minor businesses through its subsidiaries, such as properties, health food, optical glass, optical and auditory products. Wikipedia
CEO
Opgericht
2000
Website
Werknemers
25.806
